Foundry Partners, LLC Viatris Inc Transaction History
Foundry Partners, LLC
- $1.82 Billion
- Q1 2025
A detailed history of Foundry Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Foundry Partners, LLC holds 56,740 shares of VTRS stock, worth $487,396. This represents 0.03% of its overall portfolio holdings.
Number of Shares
56,740
Previous 57,790
1.82%
Holding current value
$487,396
Previous $719,000
31.29%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding VTRS
# of Institutions
1,135Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$796 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$640 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$558 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$528 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...